首页> 外文期刊>Allergy >Identification of amino acids critical for IgE-binding to sequential epitopes of bovine kappa-casein and the similarity of these epitopes to the corresponding human kappa-casein sequence.
【24h】

Identification of amino acids critical for IgE-binding to sequential epitopes of bovine kappa-casein and the similarity of these epitopes to the corresponding human kappa-casein sequence.

机译:鉴定对IgE结合牛Kappa-酪蛋白的顺序表位至关重要的氨基酸,以及这些表位与相应的人Kappa-酪蛋白序列的相似性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The delineation of allergenic (i.e. IgE-binding) epitopes in cow's milk proteins and the amino acids (AAs) critical for IgE-binding is necessary to understand better the structural properties of an allergen and to develop more efficacious immunotherapeutic reagents. Furthermore, this information may enable us to understand better cross-sensitivity between different allergens. METHODS: Eleven peptides, 10-14 AAs in length, representing the IgE-binding epitopes of kappa-casein were synthesized on a derivatized cellulose membrane with single AA substitutions at each position. Membranes were incubated with pooled sera from 15 milk-allergic patients and individual sera from 10 of the patients included in the pool. RESULTS: For 10/11 allergenic peptides, one to five different single AA substitutions resulted in elimination of IgE-binding of pooled patient sera. Overall at least one mutated peptide could be found for these 10 IgE-binding sites that resulted in a reduction of IgE-binding in at least 80% of the patients who recognized the native protein. Furthermore, the IgE-binding region at AA104-112 on bovine kappa-casein showed a high degree of similarity with the human kappa-casein, respectively, including the AAs critical for IgE-binding. CONCLUSION: This finding suggests that critical AAs should be assessed with both pooled and individual patient sera to account for the B-cell epitope heterogeneity between patients, with cow's milk allergy. In addition, we identified two potentially cross-reactive peptides between bovine and human caseins of unknown clinical relevance.
机译:背景:为了更好地了解过敏原的结构特性并开发出更有效的免疫治疗试剂,有必要对牛奶蛋白中的致敏(即IgE结合)表位和对IgE结合至关重要的氨基酸(AAs)进行描述。此外,这些信息可能使我们能够更好地了解不同过敏原之间的交叉敏感性。方法:在衍生的纤维素膜上合成11个长度为10-14 AA的肽,它们代表kappa-酪蛋白的IgE结合表位,每个位置都有一个AA取代。将膜与来自15名牛奶过敏患者的合并血清孵育,并将来自其中10名患者的单个血清孵育。结果:对于10/11变应原性肽,一到五个不同的单个AA取代导致消除了合并患者血清的IgE结合。总体上,对于这10个IgE结合位点可以发现至少一个突变的肽,导致至少80%识别天然蛋白的患者的IgE结合减少。此外,牛κ酪蛋白上AA104-112处的IgE结合区分别与人κ酪蛋白具有高度相似性,包括对IgE结合至关重要的AA。结论:这一发现提示,应对合并的和单独的患者血清进行关键AA评估,以说明患者之间的B细胞表位异质性以及牛奶过敏。此外,我们在未知临床相关性的牛和人酪蛋白之间鉴定了两个潜在的交叉反应肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号